文献速递神经核医学肿瘤 PET/CT

18F-FDG PET与高分辨率MRI融合用于常规MRI阴性的难治性颞叶外癫痫术前评估

18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-04-18

本研究前瞻性纳入67例常规MRI阴性的难治性颞叶外癫痫患者,术前行18F-FDG PET与高分辨率MRI融合并重读HR-MRI。融合后异常率由68.6%升至94.0%(P<0.05),46.3%为Change-1、11.9%为Change-2,这两组更可能被推荐手术(P<0.001);17例术后患者中88%预后良好、11.7%预后不良。作者认为融合可提高致痫起始区识别,并建议作为此类患者术前评估的标准流程。

要点

  • 67例常规MRI阴性难治性颞叶外癫痫患者前瞻性行18F-FDG PET与HR-MRI融合。
  • 融合后异常率由68.6%升至94.0%(P<0.05)。
  • Change-1占46.3%、Change-2占11.9%,更可能被推荐手术(P<0.001)。

核心结论

  • 作者认为18F-FDG PET与HR-MRI融合可提高致痫起始区的识别,并可能进一步指导手术决策、改善常规MRI正常的难治性颞叶外癫痫患者的手术结局。
  • 作者据此建议将18F-FDG PET与HR-MRI融合作为此类患者术前评估的标准流程。

研究设计与样本

  • 前瞻性纳入67例常规MRI阴性的难治性颞叶外癫痫患者,术前接受18F-FDG PET与HR-MRI检查。
  • 在18F-FDG PET与HR-MRI融合指导下重读HR-MRI图像,按首次阅读到重读的图像结果变化分为Change-1、Change-2和No-change三组。
  • 术后随访最长至59个月。

主要发现

  • 18F-FDG PET视觉分析显示46例(68.6%)存在局灶或区域异常,融合后异常率升至94.0%(P<0.05)。
  • 67例中46.3%为Change-1(重读可识别细微异常病灶),11.9%为Change-2(首次阅读报告的非特异性异常在HR-MRI重读时考虑为病灶)。
  • Change-1和Change-2患者更可能被推荐接受手术切除(P<0.001)。
  • 17例术后患者中88%结局良好,11.7%结局不良。

关键数值与推荐

  • Change-1定义为重读时可识别细微异常病灶,占46.3%。
  • Change-2定义为首次阅读报告的非特异性异常在HR-MRI重读时考虑为病灶,占11.9%。
  • 18F-FDG PET视觉分析异常46例(68.6%),融合后异常率94.0%(P<0.05)。
  • Change-1和Change-2患者更可能被推荐手术切除(P<0.001)。
  • 17例术后患者中88%结局良好、11.7%结局不良。

临床怎么用

  • 作者建议将18F-FDG PET与HR-MRI融合作为常规MRI阴性的难治性颞叶外癫痫患者术前评估的标准流程。
  • 在融合指导下重读HR-MRI可提高异常识别率,并可能指导手术决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Epilepsy that originates outside of the temporal lobe can present some of the most challenging problems for surgical therapy, especially for patients with conventional magnetic resonance imaging (MRI)-negative refractory extra-temporal lobe epilepsy (ETLE). This study aimed to evaluate the clinical value of pre-surgical 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG PET) and high-resolution MRI (HR-MRI) co-registration in patients with conventional MRI-negative refractory ETLE, and compare their surgical outcomes. METHODS: Sixty-seven patients with conventional MRI-negative refractory ETLE were prospectively included for pre-surgical 18F-FDG PET and HR-MRI examinations. Under the guidance of 18F-FDG PET and HR-MRI co-registration, HR-MRI images were re-read. Based on the image result changes from first reading to re-reading, patients were divided into three groups: Change-1 (lesions of subtle abnormality could be identified in re-read), Change-2 (non-specific abnormalities reported in the first reading were considered as lesions on HR-MRI re-read) and No-change. Post-surgical follow-ups were conducted for up to 59 months. RESULTS: Visual analysis of 18F-FDG PET showed focal or regional abnormality in 46 patients (68.6%), while the abnormal rate increased to 94.0% (P < 0.05) by co-registration. Of the 67 patients, 46.3% of them were identified as Change-1, and 11.9% as Change-2 after co-registration and HR-MRI re-read. Patients with Change-1 and -2 were more likely to be recommended to receive surgical resection (P < 0.001). In the 17 post-surgical patients, 88% had good outcomes, whereas 11.7% had poor outcomes during our study period. CONCLUSION: Pre-surgical evaluation by co-registration of 18F-FDG PET and HR-MRI could improve the identification of the epileptogenic onset zone (EOZ), and may further guide the surgical decision-making and improve the outcome of the refractory ETLE with normal conventional MRI; therefore, it should be recommended as a standard procedure for pre-surgical evaluation of these patients.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ding Y, Zhu Y, Jiang B, et al. 18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy. Eur J Nucl Med Mol Imaging. 2018. PMID: 29671038. doi:10.1007/s00259-018-4017-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。